Prognostic factors and survival in patients with hereditary hemochromatosis and cirrhosis

Canadian Journal of Gastroenterology

Volumn 20, Issue 4, 2006, Pages 257-260

  Beaton, Melanie D ^a   Adams, Paul C ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Hemochromatosis; Hepatocellular carcinoma; Iron overload

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; IRON DEPLETION; KAPLAN MEIER METHOD; LIFE TABLE METHOD; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL; UNIVARIATE ANALYSIS;

EID: 33646338600     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/428048     Document Type: Article

References (35)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
2. Adams PC. Population screening for haemochromatosis. Gut 2000;46:301-3.
3. Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening of in a racially diverse population. N Engl J Med 2005;352:1769-78.
4. Fleming RE, Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis. Annu Rev Physiol 2002;64:663-80.
5. Fargion S, Fracanzani AL, Piperno A, et al. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology 1994;20:1426-31.
6. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985;313:1256-62.
7. Tiniakos G, Williams R. Cirrhotic process, liver cell carcinoma and extrahepatic tumors in idiopathic hemochromatosis. Study of 71 patients treated with venesection therapy. Appl Pathol 1988;6:128-38.
8. Niederau C, Strohmeyer G, Stremmel W. Epidemiology, clinical spectrum and prognosis of hemochromatosis. Adv Exp Med Biol 1994;356:293-302.
9. Adams PC, Halliday JW, Powell LW. Early diagnosis and treatment of hemochromatosis. Adv Intern Med 1989;34:111-26.
10. Hellerbrand C, Poppl A, Hartmann A, Scholmerich J, Lock G. HFE C282Y heterozygosity in hepatocellular carcinoma: Evidence for an increased prevalence. Clin Gastroenterol Hepatol 2003;1:279-84.
11. Strohmeyer G, Niederau C, Stremmel W. Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y Acad Sci 1988;526:245-57.
12. Fargion S, Mandelli C, Piperno A, et al. Survival and prognostic factors in 212 Italian patients with generic hemochromatosis. Hepatology 1992;15:655-9.
13. Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 1991;101:368-72.
14. Edwards CQ, Cartwright GE, Skolnick MH, Amos DB. Homozygosity for hemochromatosis: Clinical manifestations. Ann Intern Med 1980;93:519-25.
15. Galhenage SP, Viiala CH, Olynyk JK. Screening for hemochromatosis: Patients with liver disease, families, and populations. Curr Gastroenterol Rep 2004;6:44-51.
16. McCune CA, Ravine D, Worwood M, Jackson HA, Evans HM, Hutton D. Screening for hereditary haemochromatosis within families and beyond. Lancet 2003;362:1897-8.
17. Larcos G, Sorokopud H, Berry G, Farrell GC. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: An evaluation. Am J Roentgenol 1998;171:433-5.
18. Di Bisceglie AM. Issues in screening and surveillance for hepatocellular carcinoma. Gastroenterology 2004;127:S104-7.
19. Velazquez RF, Rodriguez M, Navascues CA, et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 2003;37:520-7.
20. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: A cost effectiveness analysis. Gut 2001;48:251-9.
21. Daniele B, Bencivenga A, Megna AS, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology 2004;127:108-12.
22. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9.
23. Bennett-Guerrero E, Feierman DE, Barclay GR, et al. Preoperative and intraoperative predictors of postoperative morbidity, poor graft function, and early rejection in 190 patients undergoing liver transplantation. Arch Surg 2001;136:1177-83.
24. Austin GL, Sasaki AW, Zaman A, et al. Comparative analysis of outcome following liver transplantation in US veterans. Am J Transplant 2004;4:788-95.
25. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
26. Herrero JI, Lucena JF, Quiroga J, et al. Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant 2003;3:1407-12.
27. Collins BH, Pirsch JD, Becker YT, et al. Long-term results of liver transplantation in older patients 60 years of age and older. Transplantation 2000;70:780-3.
28. Fattovich C, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients. Gastroenterology 1997;112:463-72.
29. Fattovich C, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: A cohort study of 297 patients. Am J Gastroenterol 2002;97:2886-95.
30. Crawford DH, Fletcher LM, Hubscher SG, et al. Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis. Hepatology 2004;39:1655-62.
31. Kowdley KV, Hassanein T, Kaur S, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg 1995;1:237-41.
32. Tung BY, Farrell FJ, McCashland TM, et al. Long-term follow up after liver transplantation in patients with hepatic iron overload. Liver Transpl Surg 1999;5:369-74.
33. Brandhagen DJ. Liver transplantation for hereditary hemochromatosis. Liver Transpl 2001;7:663-72.
34. Kowdley KV, Brandhagen DJ, Gish RG, et al. Survival after liver transplantation in patients with hepatic iron overload: The national hemochromatosis transplant registry. Gastroenterology 2005;129:494-503.
35. Kilpe VE, Krakauer H, Wren RE. An analysis of liver transplant experience from 37 transplant centers as reported to Medicare. Transplantation 1993;56:554-61.